Prime Medicine Income Statement (2021-2026) | PRME

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.59M0.21M2.18M1.45M1.11M1.23M0.84M0.86M
Operating items
Research & Development (Quarter) 7.40M52.89M13.68M18.94M25.05M29.06M30.88M34.60M40.97M41.46M37.77M43.07M40.34M34.10M40.56M41.38M43.99M34.71M34.10M
Selling, General & Administrative (Quarter) 3.03M7.19M6.22M7.37M6.61M9.62M9.15M10.66M10.49M13.08M11.16M12.60M14.10M12.30M13.28M13.12M11.21M14.74M17.41M
Other Operating Expenses (Quarter) 13.50M
Operating Expenses (Quarter) 10.43M60.08M19.90M26.30M31.66M38.69M40.03M45.26M51.46M68.04M48.93M55.67M54.44M46.41M53.85M54.49M55.20M49.45M51.51M
Operating Income (Quarter) -10.43M-60.08M-19.90M-26.30M-31.66M-38.69M-40.03M-45.26M-51.46M-68.04M-48.34M-55.67M-54.23M-44.22M-52.39M-53.38M-53.97M-48.61M-50.65M
EBIT (Quarter) -10.43M-60.08M-19.90M-26.30M-31.66M-38.69M-40.03M-45.26M-51.46M-68.04M-48.34M-55.67M-54.23M-44.22M-52.39M-53.38M-53.97M-48.61M-50.65M
Non-operating items
Interest & Investment Income (Quarter) 0.64M0.41M0.49M0.68M0.61M0.70M1.54M1.18M0.74M1.14M1.08M1.02M
Other Non Operating Income (Quarter) -0.00M0.01M0.01M0.24M0.73M0.93M2.13M0.04M0.04M0.15M0.04M0.04M-0.08M0.04M0.04M0.02M0.04M0.05M0.05M
Non Operating Income (Quarter) -8.36M-1.45M-4.47M-3.48M2.52M-0.78M0.43M2.90M0.64M2.40M2.71M0.21M1.71M1.95M0.50M0.79M3.39M2.53M1.53M
Net income details
EBT (Quarter) -18.78M-61.53M-24.37M-29.79M-29.14M-39.47M-39.60M-42.35M-50.82M-65.64M-45.63M-55.46M-52.52M-42.28M-51.89M-52.59M-124.40M-47.53M-228.71M
Tax Provisions (Quarter) -2.37M1.38M-0.53M-0.44M0.21M-0.19M-0.20M0.03M-0.11M0.13M-0.13M
Profit After Tax (Quarter) -16.41M-50.55M-23.84M-29.35M-29.35M-59.48M-39.40M-42.38M-50.59M-65.51M-45.76M-55.33M-52.52M-42.28M-51.91M-52.59M-50.58M-46.00M-49.20M
Income from Non-Controlling Interests (Quarter) 0.03M-0.02M-0.01M-0.12M-0.30M0.07M0.18M-0.06M0.12M0.13M-0.08M0.02M0.09M-0.02M-0.02M0.01M0.04M0.05M-0.08M
Income from Continuing Operations (Quarter) -16.41M-62.91M-23.84M-29.35M-29.35M-39.28M-39.40M-42.38M-50.71M-65.64M-45.76M-55.33M-52.52M-42.28M-51.89M-52.59M-124.40M-47.53M-228.71M
Consolidated Net Income (Quarter) -16.41M-62.91M-23.84M-29.35M-29.35M-39.28M-39.40M-42.38M-50.71M-65.64M-45.76M-55.33M-52.52M-42.28M-51.89M-52.59M-124.40M-47.53M-228.71M
Income towards Parent Company (Quarter) -16.41M-62.91M-23.84M-29.35M-29.35M-39.28M-39.40M-42.38M-50.71M-65.64M-45.76M-55.33M-52.52M-42.28M-51.89M-52.59M-124.40M-47.53M-228.71M
Preferred Dividend Payments (Quarter) 6.36M6.22M6.29M6.36M1.31M
Net Income towards Common Stockholders (Quarter) -22.77M-69.27M-30.06M-35.64M-35.71M-40.60M-39.40M-42.38M-50.71M-65.64M-45.76M-55.33M-52.52M-42.28M-51.89M-52.59M-50.58M-46.08M-49.12M
Additional items
EPS (Basic) (Quarter) -1.52-5.34-1.58-1.76-1.61-1.20-0.44-0.47-0.55-0.72-0.44-0.46-0.44-0.36-0.40-0.41-0.32-0.31-0.28
EPS (Diluted) (Quarter) -1.52-5.34-1.58-1.76-1.61-1.20-0.44-0.47-0.55-0.72-0.44-0.46-0.44-0.36-0.40-0.41-0.32-0.31-0.28
Shares Outstanding (Quarter) 14.97M12.97M19.05M20.23M22.23M33.89M89.06M90.47M91.85M90.97M104.47M119.19M119.76M118.60M130.88M129.19M160.50M148.76M177.10M
Shares Outstanding (Diluted) (Quarter) 14.97M12.97M19.05M20.23M22.23M33.89M89.06M90.47M91.85M90.97M104.47M119.19M119.76M118.60M130.88M129.19M160.50M148.76M177.10M
EBITDA (Quarter) -10.43M-60.08M-19.90M-26.30M-31.66M-38.69M-40.03M-45.26M-51.46M-68.04M-48.34M-55.67M-54.23M-44.22M-52.39M-53.38M-53.97M-48.61M-50.65M
Interest Expenses (Quarter) 25.25M0.10M62.13M1.68M27.59M18.22M119.25M205.53M202.84M208.04M179.78M200.29M194.93M71.57M0.00M179.08M
Tax Rate (Quarter) 12.62-2.242.181.48-0.730.470.51-0.070.21-0.290.24